EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Diabetic Cardiomyopathy: Unraveling the Molecular Architecture beyond Hyperglycemia – A Narrative Review

Jaswanth Varma Alluri, Tushar Rajesh Sontakke, Sourya Acharya, Nidhi Bardiya, Atharv Chandrakant Rode

Journal of the Practice of Cardiovascular Sciences · 2025-09 · 11 (3) · 203-207

DOI: 10.4103/jpcs.jpcs_57_25 ↗
AbstractBibliografische Angaben

Abstract

Diabetic cardiomyopathy (DCM) is an increasingly recognized complication of diabetes mellitus, characterized by structural and functional changes in the myocardium independent of coronary artery disease and hypertension. Conventionally, hyperglycemia has been considered the principal pathogenic driver of DCM. However, growing evidence suggests that DCM arises from a multifactorial interplay of molecular mechanisms that extend far beyond glucose toxicity. This review aims to explore the complex molecular architecture underlying DCM, focusing on nonhyperglycemic pathways that contribute to cardiac dysfunction in diabetic patients. We highlight key mechanisms such as insulin resistance-induced metabolic remodeling, mitochondrial dysfunction leading to impaired adenosine triphosphate (ATP) production and excessive reactive oxygen species generation, chronic inflammation mediated by nuclear factor kappa-B and NLRP3 inflammasome activation, and maladaptive extracellular matrix remodeling driven by profibrotic mediators such as transforming growth factor-beta and galectin-3. Additional emphasis is placed on the roles of endoplasmic reticulum stress, defective autophagy, and epigenetic modifications, including microRNAs and histone acetylation patterns that collectively modulate cardiomyocyte survival, contractility, and remodeling. Understanding these diverse molecular contributors is essential for improving early diagnosis, identifying novel biomarkers, and developing targeted therapeutic strategies to prevent or reverse myocardial damage in diabetes. Recognizing DCM as a distinct, multifactorial entity may facilitate precision medicine approaches tailored to the underlying pathobiology in diabetic patients.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →